Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Hsu

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Seminars in Arthritis and Rheumatism|July 4, 2016
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium studyAntonia Valenzuela, Murray Baron, , et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|February 20, 2022
Change in calcinosis over 1 year using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosisAntonia Valenzuela, Kathryn Stevens, Melody P Chung, et al.
Seminars in Arthritis and Rheumatism|July 4, 2016
Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium studyAntonia Valenzuela, Murray Baron, , et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosisAntonia Valenzuela, Murray Baron, Tatiana S Rodriguez-Reyna, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 31, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical TrialDinesh Khanna, Paul Caldron, Richard W Martin, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Pageof 4